3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NIH
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Colorectal Neoplasms
26
Rectal Neoplasms
19
Colonic Neoplasms
18
Leukemia
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Lymphoma
11
Stomach Neoplasms
9
Burkitt Lymphoma
7
Pancreatic Neoplasms
5
Leukemia, Biphenotypic, Acute
4
Esophageal Neoplasms
4
Adenocarcinoma Of Esophagus
4
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasm Metastasis
3
Lymphoma, Large B-Cell, Diffuse
3
Dendritic Cell Sarcoma, Interdigitating
3
Lymphoma, Mantle-Cell
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Thrombocytopenia
1
Sarcoma
1
Rhabdoid Tumor
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Osteosarcoma
1
Neutropenia
1
Metastatic Small Intestinal Adenocarcinoma
1
Metastatic Pancreatic Adenocarcinoma
1
Medulloblastoma
1
Leukemia, Myelomonocytic, Juvenile
1
Hydatidiform Mole
1
Interventions
Razoxane
4
Doxorubicin
4
Dexrazoxane
4
Vincristine
3
Etoposide
3
Radiotherapy
2
Prednisone
2
Methotrexate
2
Granulocyte Colony-Stimulating Factor
2
Filgrastim
2
Bleomycin
2
hydrocortisone hemisuccinate
1
Watchful Waiting
1
Trastuzumab
1
Proton Therapy
1
Observation
1
Mercaptopurine
1
Leucovorin
1
Ifosfamide
1
Hydrocortisone
1
Enalapril
1
Cytarabine
1
Cyclophosphamide
1
Cisplatin
1
Carvedilol
1
Asparaginase
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Cardiotoxicity
×
Leucovorin
×
Clear all
NCT01230983
2013-06-06
T-Cell #4
Children's Oncology Group
Phase 3
Completed
573 enrolled